Abatacept reduces synovial regulatory T-cell expression in patients with psoriatic arthritis
Abstract Background The aim was to study changes in immunohistochemical expression markers of synovial and skin inflammation, clinical outcomes and magnetic resonance imaging (MRI) scores with abatacept treatment in patients with psoriatic arthritis (PsA). Methods Biological-treatment-naïve PsA pati...
Main Authors: | Agnes Szentpetery, Eric Heffernan, Martina Gogarty, Lisa Mellerick, Janet McCormack, Muhammad Haroon, Musaab Elmamoun, Phil Gallagher, Genevieve Kelly, Aurelie Fabre, Brian Kirby, Oliver FitzGerald |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-07-01
|
Series: | Arthritis Research & Therapy |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13075-017-1364-3 |
Similar Items
-
Uso do abatacepte em uma paciente com artrite psoriásica Use of the abatacept in a patient with psoriatic arthritis
by: Carlos Ewerton Maia Rodrigues, et al.
Published: (2010-06-01) -
Current treatment options for psoriatic arthritis: spotlight on abatacept
by: Ursini F, et al.
Published: (2018-06-01) -
Difficulties in choosing a biologic disease-modifying anti-rheumatic drug for the treatment of psoriasis and psoriatic arthritis
by: I. M. Marusenko, et al.
Published: (2019-03-01) -
Cardiovascular Comorbidities in Psoriatic Disease
by: Agnes Szentpetery, et al.
Published: (2019-12-01) -
Psoriatic arthritis: genetics and pathogenesis
by: A. Mathieu, et al.
Published: (2012-06-01)